Upload
alex-g-harrison
View
218
Download
5
Embed Size (px)
Citation preview
RAPID COMMUNICATIONS IN MASS SPECTROMETRY
Rapid Commun. Mass Spectrom. 2009; 23: 1298–1302
) DOI: 10.1002/rcm.4003
Published online in Wiley InterScience (www.interscience.wiley.comFragmentation reactions of some peptide b3 ions:
an energy-resolved study
Alex G. Harrison*Department of Chemistry, University of Toronto, Toronto, Canada
Received 15 January 2009; Revised 25 February 2009; Accepted 26 February 2009
*CorrespoUniversit3H6, CanE-mail: aContract/Research
The fragmentation reactions of b3 ions of nominal structure AAAoxa, YAAoxa, AYAoxa and AAYoxa
have been studied as a function of collision energy, allowing the construction of breakdown graphs
expressing in a qualitative way the energy dependence of the fragmentation reactions. The primary
fragmentation reactions of the AAAoxa b3 ion involve formation of the a3� (a3 – NH3) ion and the b2
ion, with the latter becoming the dominant product at higher internal energies. For both YAAoxa and
AYAoxa b3 ions the pathway to a3� is relatively minor with formation of b2 the dominant primary
fragmentation reaction. For the AAYoxa b3 ion, in addition to a3�, abundant formation of the tyrosine
(Y) iminium ion is observed with only minor formation of the b2 ion. The results support and expand
upon the detailed mechanism of fragmentation of b3 ions proposed by Cooper et al. (J. Am. Soc.Mass
Spectrom. 2006; 17: 1654). Copyright # 2009 John Wiley & Sons, Ltd.
Electrospray ionization (ESI)1–3 and matrix-assisted laser
desorption/ionization (MALDI)4,5 have proven to be
particularly effective in ionizing a wide variety of biological
molecules. For peptides these soft ionization techniques
produce mainly protonated (or multiply protonated) species
in the positive ion mode and collision-induced dissociation
(CID) using tandem mass spectrometric techniques6,7 has
become a widely used method particularly for obtaining the
amino acid identity and sequence in peptides. Under low-
energy CID conditions protonated peptides most often
fragment to produce N-terminal b ions and/or C-terminal
y ions;8–10 indeed, it is the series of such b ions and/or y ions
which provide sequence information. It has been clearly
established11,12 that the y ions are protonated amino acids
(y1) or protonated truncated peptides (ym); however, the
structure(s) of the b ions present a much more complicated
picture. Recent extensive studies13–17 of b2 ions have shown
that, in many cases, cyclization has occurred to form a
protonated five-membered oxazolone ring at the C-terminus
rather than retaining the acylium ion structure initially
proposed.8,9 The majority of evidence points to the bn–ym
mechanism18 for amide bond cleavage and b and y ion
formation, as illustrated in Scheme 1. When there is a strong
nucleophile in the peptide or amino acid side chain,
alternative cyclization reactions involving this nucleophile
may occur.19–22
While the results for b2 ions are consistent with an
oxazolone structure, the first direct experimental evidence
for an oxazolone structure came from elegant infrared
multiphoton dissociation (IRMPD) studies, coupled with
ndence to: A. G. Harrison, Department of Chemistry,y of Toronto, 80 St. George Street, Toronto, ON [email protected] sponsor: Natural Sciences and EngineeringCouncil (Canada).
theoretical calculations, of the b4 ion YGGF derived from
Leu-enkephalin.23,24 The comparison of the observed and
calculated IR spectra clearly indicated the oxazolone
structure. Very recently, two IRMPD studies25,26 have
confirmed the oxazolone structure for b2 ions. The studies
Scheme 1. Mechanism of amide bond cleavage.
Copyright # 2009 John Wiley & Sons, Ltd.
Scheme 2. Fragmentation pathways for b3 ions.
Peptide b3 ions 1299
of the YGGF ion also provided evidence for some population
of a fully cyclic structure for the b4 ion. A number of recent
studies27–34 have shown that larger b ions (b5 and larger) exist
to a significant extent in a fully cyclic form. This cyclic form
may open at different amide bonds resulting in non-
sequence fragment ions on further fragmentation.27–31,34
Earlier studies35,36 also provided evidence for sequence
scrambling.
On the whole peptide b3 ions have seen little study until
lately. An early brief study37 provided results consistent with
an oxazolone structure. While most bn ions with an
oxazolone structure show major fragmentation by loss of
CO to from the respective an ion,13,37,38 b3 ions are unique in
that a3 ions often are not observed in CID mass spectra38–40
although they may be observed in metastable ion mass
spectra of suitable b3 ions.37 Rather fragmentation of b3 ions
results in formation of a3� (a3 – NH3) ions and b2 ions.
Copyright # 2009 John Wiley & Sons, Ltd.
Recently, Cooper et al.41 carried out a detailed study of the
formation of the a3� ion from the GGGoxa b3 ion. Contrary to
earlier suggestions38,42 that the ammonia lost contained the
N-terminal amine, they showed that the ammonia lost
contained the nitrogen of the C-terminus residue of the b3
ion. The complex mechanism which they proposed is shown
in modified form in Scheme 2. A more recent study39 has
concluded that the b3 ion has an oxazolone structure which
loses CO to form an a3 ion which is unstable with respect to
fragmentation to the a3� and/or the b2 ion. In agreement with
an earlier computational study,43 no direct b3! b2 fragmen-
tation pathway was found. These detailed studies39,41 of
b3 ionfragmentation haveusedquadrupole iontraptechniques
and, thus, have probed low-energy fragmentation modes. It
appeared desirable to study the evolution of the fragmenta-
tion modes implicit in Scheme 2 with internal energy as well
as to study a wider range of amino acid residues. Such a
Rapid Commun. Mass Spectrom. 2009; 23: 1298–1302
DOI: 10.1002/rcm
Figure 1. Breakdown graph for the AAAoxa b3 ion derived
from AAAA.
1300 A. G. Harrison
study is reported here and reveals that the fragmentation
modes of b3 ions depends significantly on the amino acid
residues present and on their positions as well as on the
internal energy of the fragmenting ions. In particular, with
suitable b3 ions, formation of the iminium ion derived from
the C-terminal residue of the b3 ion can become a major
fragmentation reaction. This fragmentation channel is
included in the modified Scheme 2.
Figure 2. Breakdown graph for the YAAoxa b3 ion derived
from YAAAA.
EXPERIMENTAL
All experimental work was carried out using an electrospray
quadrupole time-of-flight (QqToF) mass spectrometer
(QStar, MDS Sciex, Concord, Canada). MS2 experiments
were carried out in the usual fashion for MHþ ions by
selecting the ions of interest with the quadrupole mass
spectrometer Q followed by CID in the quadrupole collision
cell q with mass analysis of the ionic products by the ToF
analyzer. In the MS3 experiments, CID in the interface region
produced fragment ions with those of interest being mass-
selected by the quadrupole Q for fragmentation and analysis
in the usual way. By varying the collision energy in the
collision cell, breakdown graphs, expressing, in a qualitative
way, the relative energy dependencies of the fragmentation
reactions, were obtained under multiple collision conditions.
Ionization was by ESI with the peptide dissolved in
1:1 CH3OH/0.1% aqueous formic acid and introduced into
the source at a flow rate of 80mL min�1. Nitrogen was used as
nebulizing gas and drying gas and as collision gas in the
quadrupole cell.
All peptide samples were obtained from Bachem Bios-
ciences (King of Prussia, PA, USA) and were used as
received.
Copyright # 2009 John Wiley & Sons, Ltd.
RESULTS AND DISCUSSION
Figures 1 to 4 present the breakdown graphs for the four b3
ions of nominal structure AAAoxa, YAAoxa, AYAoxa and
AAYoxa. In agreement with earlier work38 the two primary
fragmentation products observed for AAAoxa are the a3� ion
and the b2 ion; specifically no significant signal for the a3 ion
is observed under CID conditions although this product is
observed in metastable ion fragmentation.37 With increasing
collision energy (and, thus, internal energy) formation of
the b2 ion is distinctly favoured over formation of the a3� ion.
In effect, with increasing internal energy the intermediates III
and/or IV of Scheme 2 eliminate the loosely bound
R3CH¼NH (R3¼CH3) moiety to form b2 rather than
continue the rearrangements which eventually lead to
elimination of NH3; such rearrangements are likely to have
an unfavourable entropy of activation. That the b2 ion is
formed rather than the CH3CH¼NHþ2 iminium ion is consis-
tent with the relative proton affinities: PA(CH3CH¼ NH)¼217 kcal mol�1 44 and PA(oxazolone)¼ 222 kcal mol�1.45
These relative proton affinities indicate that the formal
proton transfer reaction IV!V is endothermic in the absence
of hydrogen bonding in the complexes. It appears that such
interactions make the proton transfer feasible. Such was
found to be the case for the GGGoxa system according to the
theoretical calculation of the potential energy surface.41 At
higher internal energies the b2 ion loses CO to form the a2 ion
and the a3� ion loses CO to formm/z 141 (structure unknown).
For both the YAAoxa and AYAoxa b3 ions CID results in
only minor formation of the a3� ion, the major primary
fragmentation reaction being formation of the b2 ion. This ion
fragments further to the a2 ion which, in turn, fragments to
form the tyrosine iminium ion (m/z 136)46 at even higher
Rapid Commun. Mass Spectrom. 2009; 23: 1298–1302
DOI: 10.1002/rcm
Figure 3. Breakdown graph for the AYAoxa b3 ion derived
from AYAAA.
Peptide b3 ions 1301
collision energies. The tyrosine residue would be expected to
increase the proton affinity of the oxazolone thus making the
proton transfer reaction IV!V less probable and largely
shutting down the ammonia elimination pathway. The
Figure 4. Breakdown graph for the AAYoxa b3 ion derived
from AAYAA. m/z 136 is tyrosine iminium ion.
Copyright # 2009 John Wiley & Sons, Ltd.
increased proton affinity of the oxazolone makes it even less
likely that the iminium ion CH3CH¼NHþ2 would be formed.
The breakdown graph for the AAYoxa b3 ion differs in that
the a3� ion and the tyrosine iminium ion (m/z 136) are the
major primary fragmentation products with only a minor
yield of the b2 ion. It is interesting that no significant a3 ion is
observed even though the tyrosine residue might have been
expected to stabilize the ion. In this system the imine
HOC6H4CH2CH¼NH has a proton affinity (225 kcal mol�1)44
greater than that of the oxazolone (222 kcal mol�1)45 making
the proton transfer reaction IV!V apparently exothermic.
In agreement, we observe substantial formation of the a3� ion
at low internal energies but simple dissociation of the
complex V at higher internal energies with preferential
formation of the tyrosine iminium ion (m/z 136) and only
minor formation of the b2 ion. Unexpectedly, a minor signal
is observed at m/z 235 corresponding to loss of an alanine
residue from the b3 ion and at m/z 207 corresponding to loss
of CO from m/z 235. It is not clear whether this represents a
small extent of full cyclization28,29 of the b3 ion with
reopening to a different sequence or whether the small
extent of cyclization/reopening has occurred for the b4 ion
which fragments extensively to form the b3 ion.
CONCLUSIONS
The present work expands on earlier studies39,41 of the
fragmentation behaviour of peptide b3 ions. The results
obtained support the detailed mechanism proposed by
Cooper et al.41 and expand on this mechanism by including
the fragmentation pathway which yields the iminium ion of
the C-terminal residue of the b3 ion. It might be noted that N-
acetylation eliminates formation of the a� ions,34 consistent
with the mechanism shown in Scheme 2. The present work
and the earlier study41 further illustrate the significant role
ion/neutral complexes play in fragmentation of peptide ions
and the important role relative proton affinities play in
determining the fragment ions which result from decompo-
sition of these complexes.18
AcknowledgementsI am indebted to the Natural Sciences and Engineering
Research Council (Canada) for continued financial support
and to Dr B. Paizs for helpful discussions and for communi-
cation of results prior to publication.
REFERENCES
1. Whitehouse CM, Dreyer RN, Yamashita M, Fenn JB. Anal.Chem. 1985; 57: 675.
2. Cole RB (ed). Electrospray Ionization Mass Spectrometry. Fun-damentals, Instrumentation and Applications. John Wiley: NewYork, 1997.
3. Pramanik BN, Ganguly AK, Gross ML (eds). Applied Electro-spray Mass Spectrometry. Marcel Dekker: New York, 2002.
4. Karas M, Hillenkamp F. Anal. Chem. 1988; 60: 2299.5. Beavis RC, Chait BT. Methods Enzymol. 1996; 270: 519.6. McLafferty FW (ed). Tandem Mass Spectrometry, John. Wiley:
New York, 1983.7. Busch KL, Glish GL, McLuckey SA. Mass Spectrometry/Mass
Spectrometry: Techniques and Applications of Tandem MassSpectrometry. VCH Publishers: New York, 1988.
8. Roepstorff P, Fohlman J. Biomed.Mass Spectrom. 1984; 11: 601.9. Biemann K. Methods Enzymol. 1990; 193: 455.
Rapid Commun. Mass Spectrom. 2009; 23: 1298–1302
DOI: 10.1002/rcm
1302 A. G. Harrison
10. Medzihradszky KF. Methods Enzymol. 2005; 402: 209.11. Mueller DR, Eckersley M, Richter W. Org. Mass Spectrom.
1988; 23: 213.12. Cordero MM, Houser JJ, Wesdemiotis C. Anal. Chem. 1993;
65: 1594.13. Yalcin T, Khouw C, Csizmadia IG, Peterson MR, Harrison
AG. J. Am. Soc. Mass Spectrom. 1995; 6: 1165.14. Nold MJ, Wesdemiotis C, Yalcin T, Harrison AG. Int. J. Mass
Spectrom. Ion Processes 1997; 164: 137.15. Paizs B, Lendvay G, Vekey K, Suhai S. Rapid Commun. Mass
Spectrom. 1999; 13: 525.16. Harrison AG, Csizmadia IG, Tang T-H. J. Am. Soc. Mass
Spectrom. 2000; 11: 427.17. Rodriquez CF, Shoeib T, Chu IK, Siu KWM, Hopkinson AC.
J. Phys. Chem. A 2000; 104: 5335.18. Paizs B, Suhai S. Mass Spectrom. Rev. 2004; 24: 508.19. Yalcin T, Harrison AG. J. Mass Spectrom. 1996; 31: 1237.20. Tu Y-P, Harrison AG. Rapid Commun. Mass Spectrom. 1998;
12: 849.21. Farrugia JM, Taverner T, O’Hair RAJ. Int. J. Mass Spectrom.
2001; 209: 99.22. Farrugia JM, O’Hair RAJ, Reid GA. Int. J. Mass Spectrom.
2001; 210/211: 71.23. Polfer NC, Oomens J, Suhai S, Paizs B. J. Am. Chem. Soc. 2005;
127: 17154.24. Polfer NC, Oomens J, Suhai S, Paizs B. J. Am. Chem. Soc. 2007;
129: 5887.25. Yoon SH, Chamot-Rooke J, Perkins BR, Hilderbrand AE,
Poutsma JC, Wysocki VH. J. Am. Chem. Soc. 2008; 130:17644.
26. Oomens J, Young S, Molesworth S, Van Stipdonk M. J. Am.Soc. Mass Spectrom. 2009; 20: 334.
27. Yague J, Paradela A, Ramos M, Ogueta S, Barabona F, Lopezde Castro JA, Vazquez J. Anal. Chem. 2003; 75: 1524.
Copyright # 2009 John Wiley & Sons, Ltd.
28. Harrison AG, Young AB, Bleiholder C, Suhai S, Paizs B.J. Am. Chem. Soc. 2006; 128: 10364.
29. Bleiholder C, Osburn S, Williams TD, Suhai S, Van StipdonkM, Harrison AG, Paizs B. J. Am. Chem. Soc. 2008; 130: 17774.
30. C, Qi W, He Z. J. Am. Soc. Mass Spectrom. 2007; 18: 663.31. Mouls L, Aubagnac J-L, Martinez J, Enjalbal C. J. Proteome
Res. 2007; 6: 1378.32. Riba-Garcia I, Giles K, Bateman RH, Gaskell SJ. J. Am. Soc.
Mass Spectrom. 2008; 19: 609.33. Polfer NC, Bohrer BC, Plasencia MD, Paizs B, Clemmer DE.
J. Phys. Chem A 2008; 108: 1286.34. Harrison AG. J. Am. Soc. Mass Spectrom. 2008; 19: 1776.35. Tang XJ, Thibault P, Boyd RK. Anal. Chem. 1993; 65: 2824.36. Tang XJ, Boyd RK. Rapid Commun. Mass Spectrom. 1994; 8:
678.37. Yalcin T, Csizmadia IG, Peterson MR, Harrison AG. J. Am.
Soc. Mass Spectrom. 1996; 7: 233.38. Harrison AG, Young AB. J. Am. Soc. Mass Spectrom. 2004; 15:
1810.39. Allen JM, Racine AH, Berman AM, Johnson JS, Bythell BJ,
Paizs B, Glish GL. J. Am. Soc. Mass Spectrom. 2008; 19: 1764.40. Savitski MM, Falth M, Fung YME, Adams CM, Zubarev RA.
J. Am. Soc. Mass Spectrom. 2008; 19: 1755.41. Cooper T, Talaty E, Grove J, Van Stipdonk M, Suhai S, Paizs
B. J. Am. Soc. Mass Spectrom. 2006; 17: 1654.42. Vachet RW, Bishop BM, Erickson BW, Glish GL. J. Am. Chem.
Soc. 1997; 119: 5481.43. Fang DC, Yalcin T, Tang TH, Fu XY, Harrison AG, Csizma-
dia IG. J. Mol. Struct. (Theochem). 1999; 468: 135.44. Paizs B, Schnolzer M, Warnken U, Suhai S, Harrison AG.
Phys. Chem. Chem. Phys. 2004; 6: 2691.45. Paizs B, Suhai S. J. Am. Soc. Mass Spectrom. 2004; 15: 103.46. Harrison AG, Young AB, Schnolzer M, Paizs B. Rapid Com-
mun. Mass Spectrom. 2004; 18: 1635.
Rapid Commun. Mass Spectrom. 2009; 23: 1298–1302
DOI: 10.1002/rcm